Showing 3,481 - 3,500 results of 4,404 for search '"Clinical trial"', query time: 0.11s Refine Results
  1. 3481

    Effect of music therapy on behavioral and physiological neonatal outcomes: A systematic review and dose-response meta-analysis. by Fatemeh Shahbazi, Marzieh Fattahi-Darghlou, Samad Moslehi, Minoo Dabiri-Golchin, Marjan Shahbazi

    Published 2025-01-01
    “…The inclusion criteria comprised randomized clinical trials that investigated the effects of music therapy on improving adverse neonatal outcomes. …”
    Get full text
    Article
  2. 3482

    The Taking Charge After Stroke (TaCAS) study protocol: a multicentre, investigator-blinded, randomised controlled trial comparing the effect of a single Take Charge session, two Ta... by Mark Weatherall, Harry McNaughton, Vivian Wai Yin Fu

    Published 2017-06-01
    “…Results will be published and presented at relevant stroke meetings within New Zealand and internationally, informing the use of a self-management intervention after stroke.Trial registration Australia and New Zealand Clinical Trials Registry ACTRN12615001163594. Date registered 02-11-2015. …”
    Get full text
    Article
  3. 3483

    Surveillance of drug prescribing: why outliers miss their targets – a qualitative study by Julia Gollnick, Nikoletta Zeschick, Franziska Hörbrand, Peter Killian, Maria Sebastiao, Thomas Kühlein, Norbert Donner-Banzhoff

    Published 2025-01-01
    “…Trial registration This trial has been registered in the German Register of Clinical Trials (DRKS: DRKS00016161; registration date 07. …”
    Get full text
    Article
  4. 3484

    Evaluation of a Low-threshold Exercise And Protein supplementation intervention for Women (LEAP-W) experiencing homelessness and addiction: Protocol for a single-arm mixed methods... by Fiona Kennedy, Deirdre Murray, Clíona Ní Cheallaigh, Roman Romero-Ortuno, Julie Broderick

    Published 2025-01-01
    “…The findings of this research will help narrow the research gap and will guide clinicians and policy makers to implement unique gender-based treatment strategies for this population. (300).<h4>Clinical trials.gov number</h4>NCT05700305.…”
    Get full text
    Article
  5. 3485
  6. 3486
  7. 3487

    Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch

    Published 2022-07-01
    “…Rheumatologists should be aware of dermatologic manifestations and QoL impacts in patients with PsA.ClinicalTrials.gov NCT01877668; NCT01882439…”
    Get full text
    Article
  8. 3488

    Effect of electrical stimulation with a cochlear implant on tinnitus impact: protocol of an individual patient data meta-analysis by Inge Stegeman, Adriana L Smit, Kelly Assouly

    Published 2022-06-01
    “…We will also apply prediction models to individual patient data (IPD) of clinical trials to find predictive factors of the effect of electrical stimulation on tinnitus impact.Method and analysis The IPD meta-analysis is a follow-up project of the systematic review on cochlear implantation in patients with tinnitus as a primary complaint. …”
    Get full text
    Article
  9. 3489

    High and Low Adherence to Mediterranean and DASH Diet Patterns and the Risk of Heart Failure: A Meta-Analysis of Observational Studies by Mehmet Emin Arayici, Mustafa Eray Kilic, Mehmet Birhan Yilmaz

    Published 2025-01-01
    “…A comprehensive literature search was undertaken for published papers in PubMed, Embase, EBSCO, ICTRP, and the NIH clinical trials databases. Results. A total of 16 reports from 14 studies were included in this paper. …”
    Get full text
    Article
  10. 3490

    Knowledge on hydroxychloroquine prescription and attitude toward its use in COVID-19 – A survey-based study among doctors by T P Afra, N A Uvais, Anuradha Bishnoi, Edavalath Sukesh, Salin Eliyas, N A Bishurul Hafi, T Muhammed Razmi

    Published 2021-01-01
    “…A significantly higher number of these physicians opposed the use of HCQ in clinical trials (26.82% vs. 8.1%, P = 0.027) and health-care/contact prophylaxis (41.5% vs. 16.2%, P = 0.008). …”
    Get full text
    Article
  11. 3491

    Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia by Melea A. Ward, Gang Fang, Kristy L. Richards, Christine M. Walko, Stephanie R. Earnshaw, Laura E. Happe, Susan J. Blalock

    Published 2015-04-01
    “…**Background:** Research has shown that treatment interruptions are associated with worse failure-free survival in chronic myeloid leukemia (CML); however they are commonly used in clinical trials to manage adverse events. **Objectives:** This study assessed the comparative rates of treatment interruption and regimen change between patients initiating first-line therapy with a first-generation tyrosine kinase inhibitor (1GTKI) imatinib versus second-generation TKI (2GTKI), dasatinib or nilotinib, for the treatment of CML in clinical practice. …”
    Get full text
    Article
  12. 3492

    Gene expression profiling in B-cell non-Hodgkin lymphomas by Renas N. Saleem, Ahmed Khudair Yassin

    Published 2024-12-01
    “…CONCLUSIONS: These B-NHL-expressed genes may be considered potential diagnostic markers with their meaningful comparisons to control groups, and they could be proposed to guide the management of patients and facilitate their stratification into clinical trials.…”
    Get full text
    Article
  13. 3493

    Beliefs about HIV cure: A qualitative study of people living with HIV in Soweto, South Africa by Fatima Laher, Naledi Mahlangu, Mbalenhle Sibiya

    Published 2025-01-01
    “…Background: Rare cases of HIV cure exist. Clinical trials of HIV cure are also underway. However, little is documented about how potential cures are perceived by African people living with HIV, although they are key stakeholders. …”
    Get full text
    Article
  14. 3494

    A randomized, double‐blind, placebo‐controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease by Darren Bentley, Marie Mannino, Marianne Manchester, Priscila Camillo Teixeira, Bernhard Reis, Malcolm Boyce, Sandra Nagel

    Published 2025-01-01
    “…This randomized, double‐blind, placebo‐controlled, parallel‐group, single‐center study tested the effects of the cathepsin S inhibitor RO5459072 on the immune response to a 13‐day gluten challenge in 19 participants with celiac disease (ClinicalTrials.gov: NCT02679014). Nine participants in the RO5459072 arm received 100 mg study drug b.i.d. (200 mg daily); 10 received a placebo. …”
    Get full text
    Article
  15. 3495

    Association of dietary sodium intake with impaired fasting glucose in adult cancer survivors: A population-based cross-sectional study. by Kyuwoong Kim, Hamee Kim, Tae Joon Jun, Young-Hak Kim

    Published 2023-01-01
    “…Well-designed cohort studies or randomized clinical trials are needed to establish more epidemiologic evidence on this association in adult cancer survivors.…”
    Get full text
    Article
  16. 3496
  17. 3497

    Permeability of the blood-brain barrier through the phases of ischaemic stroke and relation with clinical outcome: protocol for a systematic review by Helena Donato, Sara Bernardo-Castro, Lino Ferreira, João Sargento-Freitas

    Published 2020-09-01
    “…In addition, grey literature and ClinicalTrials.gov will be scanned. We will include randomised controlled trials, cohort, cross-sectional and case-controlled studies on humans that quantitatively assess the BBBP in stroke. …”
    Get full text
    Article
  18. 3498

    Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review by Siddharth Shah, Hadeel M. Mansour, Brandon Lucke-Wold

    Published 2025-01-01
    “…There is strong evidence supporting the transplantation of stem cells or their derivatives in HD animal models, even if stem-cell-based preclinical and clinical trials are still in their early stages. Current treatment only aims at relieving the symptoms rather than treating the pathogenesis of the disease. …”
    Get full text
    Article
  19. 3499

    The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity by Lynda Bourebaba, Anna Serwotka-Suszczak, Nabila Bourebaba, Magdalena Zyzak, Krzysztof Marycz

    Published 2023-01-01
    “…Taken together, the presented data suggest that the PTP1B inhibition strategy and the use of its specific inhibitor MSI-1436 represents a promising option for the improvement of liver tissue integrity and homeostasis in the course of EMS and adds more insights for ongoing clinical trials for human MetS management.…”
    Get full text
    Article
  20. 3500